Stockscreener 앱 받기
19.03
4.62%
0.84
시간 외 거래:
19.29
0.26
+1.37%
Summit Therapeutics Inc 주식(SMMT)의 최신 뉴스
Here’s Why Analysts Are Bullish on Summit Therapeutics Inc. (SMMT) - Insider Monkey
Long Term Trading Analysis for (SMMT) - Stock Traders Daily
Is Summit Therapeutics (SMMT) the Best Russell 2000 Stock to Invest in According to Analysts? - MSN
Summit Therapeutics (SMMT) Stock Price, News & Analysis - MarketBeat
Summit Therapeutics (NASDAQ:SMMT) Trading 6.5% HigherWhat's Next? - MarketBeat
Summit Therapeutics: Data Signals A Potential Paradigm Shift In NSCLC (Rating Upgrade) - Seeking Alpha
Summit Therapeutics (NASDAQ:SMMT) Trading Down 6.3%Here's What Happened - MarketBeat
Looking At Summit Therapeutics's Recent Unusual Options Activity - Benzinga
24,879 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Bought by SeaCrest Wealth Management LLC - MarketBeat
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Summit Therapeutics (SMMT) Stock Surge Driven by Promising Drug Trials - GuruFocus.com
Why Summit Therapeutics Rocketed 584% in 2024 - MSN
Summit Therapeutics Highlights Success at Healthcare Conference - TipRanks
Summit Therapeutics (NASDAQ:SMMT) Stock Quotes, Forecast and News Summary - Benzinga
(SMMT) Technical Data - Stock Traders Daily
Summit Therapeutics (NASDAQ:SMMT) Shares Up 3.3%Should You Buy? - MarketBeat
Merck rival Summit draws new buy from Truist on deal prospects - Seeking Alpha
Summit Therapeutics (NASDAQ:SMMT) Now Covered by Analysts at Truist Financial - MarketBeat
Truist Securities Initiates Coverage of Summit Therapeutics (SMMT) with Buy Recommendation - MSN
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside - Benzinga
Summit Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
SA Asks: Which biotechs are most likely to be acquired near-term? - Seeking Alpha
The Play On Summit Therapeutics (NASDAQ:SMMT) - Seeking Alpha
Summit Therapeutics Inc. (NASDAQ:SMMT) Receives $33.33 Consensus PT from Analysts - MarketBeat
Prediction: These 3 Healthcare Stocks Will Soar in 2025 - Yahoo Finance
Why Is Summit Therapeutics Inc. (SMMT) Among the Best Multibagger Stocks to Buy Right Now? - Insider Monkey
12 Best Multibagger Stocks to Buy Right Now - Insider Monkey
Insider Stock Buying Reaches US$78.8m On Summit Therapeutics - Simply Wall St
3 Stocks That Could Be Monster Winners in 2025 - Yahoo Finance
Here are Morgan Stanley’s key oncology catalysts for 2025 - Seeking Alpha
Summit Therapeutics (NASDAQ:SMMT) Trading Down 6.2%Here's Why - MarketBeat
103,276 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Bought by Franklin Resources Inc. - MarketBeat
10 Best Performing Biotech Stocks in 2024 - Insider Monkey
Is Summit Therapeutics Inc. (SMMT) the Best Performing Biotech Stock in 2024? - Insider Monkey
Geode Capital Management LLC Increases Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat
Barclays PLC Sells 137,195 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat
Why Did Summit Therapeutics Inc. (SMMT) Jump Yesterday? - MSN
Why These 10 Stocks Jumped Yesterday - Insider Monkey
Where Will Summit Therapeutics Be in 5 Years? - Yahoo Finance
3 Stocks That Could Turn $1,000 into $5,000 by 2030 - The Motley Fool
Wellington Management Group LLP Sells 223,964 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat
Summit Therapeutics (NASDAQ:SMMT) Trading Up 6.8%Should You Buy? - MarketBeat
(SMMT) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Has Summit Therapeutics Stock Already Peaked? - AOL
State Street Corp Sells 654,623 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat
Here's Why Summit Therapeutics Stock Price Rose 6% on Friday - MSN
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street - Yahoo! Voices
Virtu Financial LLC Makes New Investment in Summit Therapeutics Inc. (NASDAQ:SMMT) - MarketBeat
Wells Fargo Initiates Coverage of Summit Therapeutics (SMMT) with Overweight Recommendation - MSN
0.75%
2.31%
자본화:
|
볼륨(24시간):